Antiproliferative effect of the isoquinoline alkaloid papaverine in hepatocarcinoma HepG-2 cells - Inhibition of telomerase and induction of senescence

Molecules

Volumn 19, Issue 8, 2014, Pages 11846-11859

  Noureini, Sakineh Kazemi ^a   Wink, Michael ^b  

^a HAKIM SABZEVARI UNIVERSITY   (Iran)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

Immortality; Papaverine; Senescence; Telomerase

Indexed keywords

ALKALOID; ANTINEOPLASTIC AGENT; ISOQUINOLINE; ISOQUINOLINE DERIVATIVE; PAPAVERINE; TELOMERASE;

AGING; ANTAGONISTS AND INHIBITORS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL AGING; CELL PROLIFERATION; DRUG EFFECTS; HEPG2 CELL LINE; HUMAN; LIVER NEOPLASMS; METABOLISM; PATHOLOGY; TELOMERE;

AGING; ALKALOIDS; ANTINEOPLASTIC AGENTS; APOPTOSIS; CARCINOMA, HEPATOCELLULAR; CELL AGING; CELL PROLIFERATION; HEP G2 CELLS; HUMANS; ISOQUINOLINES; LIVER NEOPLASMS; PAPAVERINE; TELOMERASE; TELOMERE;

EID: 84906673921     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190811846     Document Type: Article

References (32)

1. Greider, C.W.; Blackburn, E.H. Telomeres, telomerase and cancer. Sci. Am. 1996, 274, 92-97.
2. Smith, L.L.; Coller, H.A. Telomerase modulates expression of growth-controlling genes and enhances cell proliferation. Nat. Cell Biol. 2003, 5, 474-479.
3. Zheng, Y.L.; Zhang, F. Telomerase enzymatic component hTERT shortens long telomeres in human cells. Cell Cycle 2014, 11, 1765-1776.
4. Jiang, H.; Ju, Z. Telomere shortening and ageing. Z. Gerontol. Geriatr. 2007, 40, 314-324.
5. Stadtfeld, M.; Nagaya, M. Induced pluripotent stem cells generated without viral integration. Science 2008, 322, 945-949.
6. Reig-Viader, R.; Vila-Cejudo, M. Telomeric repeat-containing RNA (TERRA) and telomerase are components of telomeres during mammalian gametogenesis. Biol. Reprod. 2014, doi:10.1095/biolreprod.113.116954.
7. Armanios, M. Telomeres and age-related disease: How telomere biology informs clinical paradigms. J. Clin. Invest. 2013, 123, 996-1002.
8. Günes, C.; Rudolph, K.L. The role of telomeres in stem cells and cancer. Cell 2013, 152, 390-393.
9. Shay, J.W.; Wright, W.E. Telomerase: A target for cancer therapeutics. Cancer Cell 2002, 2, 257-265.
10. Hsu, Y.; Lin, J.J. Telomere and telomerase as targets for anti-cancer and regeneration therapies. Acta Pharmacol. Sin. 2005, 26, 513-518.
11. Turano, A.; Scura, G. Inhibitory effect of papaverine on HIV replication in vitro. AIDS Res Hum Retroviruses. AIDS Res. Hum. Retrovir. 1989, 5, 183-192.
12. Nohl, H.; Rohr-Udilova, N. Ubiquinol and the papaverine derivative caroverine prevent the expression of tumour-promoting factors in adenoma and carcinoma colon cancer cells induced by dietary fat. BioFactors 2005, 25, 87-95.
13. Pöch, G.; Kukovetz, W.R. Papaverine-induced inhibition of phosphodiesterase activity in various mammalian tissues. Life Sci. 1971, 10, 133-144.
14. Friedman, Z.; Hackett, S.F. Human retinal pigment epithelial cells in culture possess A2-adenosine receptors. Brain Res. 1989, 492, 29-35.
15. Hultman, K.A.; Scott, A.W. Small molecule modifier screen for kit-dependent functions in zebrafish embryonic melanocytes. Zebrafish 2008, 5, 279-287.
16. Ahmad, N.; Gupta, S. Differential antiproliferative and apoptotic response of sanguinarine for cancer cells versus normal cells. Clin. Cancer Res. 2000, 6, 1524-1528.
17. Noureini S.K.; Wink, M. Transcriptional down regulation of hTERT and induction of senescence in HepG2 cells by the benzophenanthridine alkaloid chelidonine. World J. Gastroenterol. 2009, 15, 3603-3610.
18. Huang, Y.H.; Wu, J.C. Survival benefit of transcatheter arterial chemoembolization in patients with hepatocellular carcinoma larger than 10 cm in diameter. Aliment. Pharmacol. Ther. 2006, 23, 129-135.
19. Mizukoshi, E.; Nakamoto, Y. Cytotoxic T cell responses to human telomerase reverse transcriptase in patients with hepatocellular carcinoma. Hepatology 2006, 43, 1284-1294.
20. Ko, E.; Jung, G. Positive association of long telomeres with the invasive capacity of hepatocellular carcinoma cells. Biochem. Biophys. Res. Commun. 2014, 447, 358-363.
21. Rubis, B.; Kaczmarek, M. The biological activity of G-quadruplex DNA binding papaverine-derived ligand in breast cancer cells. Invest. New Drugs 2009, 27, 289-296.
22. Counter, C.M.; Meyerson, M. Telomerase activity is restored in human cells by ectopic expression of hTERT (hEST2). Oncogene 1998, 16, 1217-1222.
23. Mosmann, T. Rapid colorimetric assay for cellular growth and survival, application to proliferation and cytotoxicity assays. J. Immunol. Methods 1983, 65, 55-63.
24. Kim, N.W.; Piatyszek, M.A. Specific association of human telomerase activity with immortal cells and cancer. Science 1994, 266, 2011-2050.
25. Bradford, M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 1976, 72, 248-254.
26. Hou, M.; Dawei, X. Real-time quantitative telomeric repeat amplification protocol assay for the detection of telomerase activity. Clin. Chem. 2001, 47, 519-524.
27. Noureini, S.K.; Wink, M. Antiproliferative effects of crocin in HepG-2 cells by telomerase inhibition and hTERT down-regulation. Asian Pac. J. Cancer Prev. 2012, 13, 2305-2309.
28. Sriwilaijareon, N.; Petmitr, S.; Mutirangura, A.; Ponglikitmongkol, M.; Wilairat, P. Stage specificity of Plasmodium falciparum telomerase and its inhibition by berberine. Parasitol. Int. 2002, 51, 99-103.
29. Mergny, J.L.; Lacroix, L. Telomerase inhibitors based on quadruplex ligands selected by a fluorescent assay. Proc. Natl. Acad. Sci. USA 2001, 98, 3062-3067.
30. Stewart, C.R. Broadening by acridine orange of the thermal transition of DNA. Biopolymers 1968, 6, 1737-1743.
31. Dimri, G.P.; Lee, X.; Basile, G.; Acosta, M.; Scott, G.; Roskelley, C.; Medrano, E.E.; Linskens, M.; Rubelj, I.; Pereira-Smith, O. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. USA 1995, 92, 9363-9367.
32. Wang, Y.; Liu, Q.; Liu, Z.; Li, B.; Sun, Z.; Zhou, H.; Zhang, X.; Gong, Y.; Shao, C. Berberine, a genotoxic alkaloid, induces ATM-Chk1 mediated G2 arrest in prostate cancer cells. Mutat. Res. 2012, 734, 20-29.